Category Archives: GI
This large trial of patients with a relative contraindication for enteral feeds were randomized to early TPN or usual care. There were no differences in the groups in 60 day mortality or LOS, but those on TPN did have a … Continue reading
The American Association for the Study of Liver Disease has released guidelines on the management of ascites. Among the recommendations, some include: use caution when prescribing agents that lower arterial blood pressure (such as ACE/ARBs), avoid the vaptan drugs, and … Continue reading
This online risk calculator can help clinicians weigh the risks and benefits of ASA for individual patients (calculator).
This cohort of elderly patients discharged from acute care found a higher risk of mortality among those discharged on a PPI versus no PPI. Although only hypothesis generating at this point, this study should give us pause when discharging elderly … Continue reading
The new xTAG GI pathogen panel has been approved by the FDA, which tests for: Bacteria (Campylobacter, C. difficile toxin A/B, E. coli O157, Enterotoxigenic E.coli, Salmonella, Shigella, and Shiga?like Toxin producing E. coli), Viruses (Norovirus and Rotavirus) and Parasites (Cryptosporidium and Giardia) (FDA site).
In this trial of patients with recurrent Cdiff, they were treated with vancomycin, then randomized to no further therapy, duodenal lavage, or duodenal infusion of donor feces. Those in the donor feces group had 81% resolution of disease at 10 … Continue reading
In this trial of patients intubated and receiving tube feedings, they were randomized to measuring gastric residuals or not measuring gastric residuals. Those that did not have their gastric residuals measured had the same risk of VAP, and higher attainment … Continue reading
In this small single center prospective cohort, patients with suspected Cdiff submitted a stool sample and a rectal swab for PCR testing. The rectal swab was found to have a sensitivity and specificity of 96% and 100% respectively. This may … Continue reading
This large single center cohort found several factors associated with the risk of non-ICU GI bleeding; researchers developed a scoring system to determine which patients were at highest risk of bleeding (and presumably would benefit from GI prophylaxis). The following … Continue reading